P0110 Safety and anti-tumour activity of pegylated recombinant human IL-10 (AM0010) in selected advanced solid tumours
Naing, A, Infante, J.R, Papadopoulos, K.P, Autio, K.A, Ott, P.A, Falchook, G, Wong, D, Whiteside, M, Oft, M
Published in European journal of cancer (1990) (01.07.2015)
Published in European journal of cancer (1990) (01.07.2015)
Get full text
Journal Article
Overall responses and survival in RCC on pegilodecakin with anti-PD-1
Naing, A., Infante, J.R., Wong, D.J., Korn, W.M., Aljumaily, R., Papadopoulos, K.P., Autio, K.A., Pant, S., Bauer, T.M., Drakaki, A., Daver, N.G., Hung, A., Verma, R., Ratti, N., McCauley, S., Van Vlasselaer, P., Tannir, M., Oft, M.
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
Durability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy
Autio, K.A., Naing, A., Hung, A., Oft, M., Leveque, J., Falchook, G.S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy
Naing, A., Autio, K.A., Falchook, G.S., Meric-Bernstam, F., Litton, J.K., Ibrahim, N.K., Hung, A., Oft, M., Leveque, J., Patel, M.R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
Boni, V, Garcia-Corbacho, J, Ott, P A, Cho, D C, Autio, K A, Uboha, N, Spira, A I, Humphrey, R, Will, M, Naing, A, Thistlethwaite, F, de Vries, E G E, Arkenau, H-T
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Responses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in combination with anti-PD-1 inhibitors
Tannir, N.M., Naing, A., Papadopoulos, K.P., Wong, D.J., Korn, W.M., Aljumaily, R., Autio, K.A., Pant, S., Bauer, T.M., Drakaki, A., Daver, N., Hung, A., Oft, M., Leveque, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors
Plummer, R, Sanborn, R E, de Vries, E G E, Lorusso, P, Arkenau, H-T, Uboha, N, Wydmanski, J, Fidler, M J, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, K A, El-Khoueiry, A B, Menke-van der Houven van Oordt, C W, Thistlethwaite, F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX)
Hecht, J.R., Naing, A., Falchook, G.S., Patel, M.R., Aljumaily, R., Wong, D.J., Autio, K.A., Wainberg, Z.A., Javle, M., Bendell, J., Pant, S., Hung, A., Oft, M., Leveque, J., Papadopoulos, K.P.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Responses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors
Garon, E.B., Wong, D.J., Schneider, J.G., Aljumaily, R., Korn, W.M., Patel, M.R., Autio, K.A., Papadopoulos, K.P., Naing, A., Gabrail, N., Munster, P.N., Goldman, J., Hung, A., Oft, M., Leveque, J., Spigel, D.R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
Naing, A., Papadopoulos, K.P., Autio, K.A., Ott, P.A., Patel, M.R., Wong, D.J., Falchook, G., Pant, S., Whiteside, M., Rasco, D., Patnaik, A., Bendell, J.C., Bauer, T.M., Colen, R.R., Hong, D., Van Vlasselaer, P., Brown, G.L., Oft, M., Tannir, N., Infante, J.R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article